
    <!DOCTYPE html>
    <html>
    <head>
        <style>
            body { 
                font-family: 'Segoe UI', Roboto, -apple-system, sans-serif; 
                max-width: 1200px; 
                margin: 0 auto; 
                padding: 20px; 
                background-color: #f0f2f5;
                line-height: 1.6;
            }
            .container { 
                background-color: white; 
                padding: 40px; 
                border-radius: 16px; 
                box-shadow: 0 4px 12px rgba(0,0,0,0.1);
            }
            .agent-section { 
                margin-bottom: 35px; 
                padding: 25px; 
                border-radius: 12px; 
                transition: all 0.3s ease;
            }
            .agent-section:hover {
                transform: translateY(-2px);
                box-shadow: 0 4px 15px rgba(0,0,0,0.1);
            }
            .final-annotation { 
                background-color: #f0f7ff; 
                border-left: 5px solid #2196f3; 
            }
            .validator { 
                background-color: #f0fdf4; 
                border-left: 5px solid #22c55e; 
            }
            .formatting { 
                background: linear-gradient(145deg, #fff7ed, #ffe4c4);
                border-left: 5px solid #f97316; 
                box-shadow: 0 4px 15px rgba(249, 115, 22, 0.1);
            }
            h2 { 
                color: #1a2b3c; 
                margin-top: 0; 
                font-size: 1.5rem;
                font-weight: 600;
                display: flex;
                align-items: center;
                gap: 10px;
            }
            ul { 
                margin: 15px 0; 
                padding-left: 20px; 
            }
            pre { 
                background-color: #f8fafc; 
                padding: 20px; 
                border-radius: 8px; 
                overflow-x: auto;
                font-family: 'Consolas', 'Monaco', monospace;
                font-size: 0.9rem;
                line-height: 1.5;
            }
            .validation-result { 
                font-weight: 600; 
                color: #16a34a; 
                padding: 12px 20px;
                background-color: #dcfce7; 
                border-radius: 8px; 
                display: inline-block;
                margin: 10px 0;
            }
            br { 
                margin-bottom: 8px; 
            }
            p {
                margin: 12px 0;
                color: #374151;
            }
            .summary-content {
                display: flex;
                flex-direction: column;
                gap: 24px;
            }
            .summary-item {
                display: flex;
                flex-direction: column;
                gap: 8px;
                background: rgba(255, 255, 255, 0.7);
                padding: 16px;
                border-radius: 12px;
                backdrop-filter: blur(8px);
                box-shadow: 0 2px 8px rgba(0, 0, 0, 0.05);
            }
            .summary-label {
                font-weight: 600;
                color: #c2410c;
                font-size: 0.95rem;
                text-transform: uppercase;
                letter-spacing: 0.5px;
            }
            .summary-value {
                color: #1f2937;
                font-size: 1.1rem;
                padding: 8px 16px;
                background-color: rgba(255, 255, 255, 0.9);
                border-radius: 8px;
                display: inline-block;
                box-shadow: 0 1px 3px rgba(0, 0, 0, 0.1);
            }
            .summary-list {
                margin: 0;
                padding-left: 24px;
                list-style-type: none;
            }
            .summary-list li {
                color: #1f2937;
                padding: 8px 0;
                position: relative;
            }
            .summary-list li:before {
                content: "‚Ä¢";
                color: #f97316;
                font-weight: bold;
                position: absolute;
                left: -20px;
            }
            .report-header {
                text-align: center;
                margin-bottom: 40px;
                padding-bottom: 30px;
                border-bottom: 2px solid rgba(249, 115, 22, 0.2);
            }
            
            .report-title {
                font-size: 2.5rem;
                font-weight: 800;
                color: #1a2b3c;
                margin: 0;
                padding: 0;
                background: linear-gradient(135deg, #f97316, #c2410c);
                -webkit-background-clip: text;
                -webkit-text-fill-color: transparent;
                letter-spacing: -0.5px;
            }
            
            .report-subtitle {
                font-size: 1.1rem;
                color: #64748b;
                margin-top: 8px;
                font-weight: 500;
            }
            .scoring { 
                background: linear-gradient(145deg, #f0fdf4, #dcfce7);
                border-left: 5px solid #22c55e;
                box-shadow: 0 4px 15px rgba(34, 197, 94, 0.1);
            }
            .scoring-content {
                display: flex;
                flex-direction: column;
                gap: 16px;
                color: #1f2937;
                line-height: 1.8;
            }
            .scoring-content br + br {
                content: "";
                display: block;
                margin: 12px 0;
            }
            .empty-list {
                color: #6b7280;
                font-style: italic;
            }
            .error-message {
                color: #dc2626;
                padding: 12px;
                background-color: #fef2f2;
                border-radius: 6px;
                border-left: 4px solid #dc2626;
            }
            .score-badge {
                background: linear-gradient(135deg, #22c55e, #16a34a);
                color: white;
                padding: 8px 16px;
                border-radius: 12px;
                font-size: 1.5rem;
                font-weight: 700;
                display: inline-block;
                margin: 12px 0;
                box-shadow: 0 4px 12px rgba(34, 197, 94, 0.2);
                position: relative;
                top: -10px;
            }
            .score-badge::before {
                content: "Score:";
                font-size: 0.9rem;
                font-weight: 500;
                margin-right: 8px;
                opacity: 0.9;
            }
        </style>
    </head>
    <body>
        <div class="container">
            <div class="report-header">
                <h1 class="report-title">CASSIA Analysis Report</h1>
                <p class="report-subtitle">Comprehensive Cell Type Analysis and Annotation</p>
            </div>
            
                <div class="agent-section final-annotation">
                    <h2>üîç Final Annotation Analysis</h2>
                    To annotate the cell type based on the provided ranked marker list from a single-cell human dataset derived from breast cancer tissue, I will follow the outlined steps:<br><br>### Step 1: List the Key Functional Markers<br>- **S100A7, S100P, S100A14**: Members of the S100 protein family, often associated with inflammation and cancer progression.<br>- **TFF1, TFF3**: Trefoil factors involved in mucosal protection and repair, often expressed in epithelial tissues.<br>- **AREG (Amphiregulin)**: A growth factor involved in epithelial cell proliferation and a known ligand for the epidermal growth factor receptor (EGFR).<br>- **FASN (Fatty Acid Synthase)**: An enzyme involved in lipogenesis, often upregulated in cancer cells.<br>- **MUC1**: A mucin protein involved in forming protective mucous barriers on epithelial surfaces, often overexpressed in breast cancer.<br>- **SDC1 (Syndecan-1)**: A cell surface proteoglycan involved in cell proliferation, cell migration, and cell-matrix interactions.<br><br>### Step 2: List the Key Cell Type Markers<br>- **KRT18, KRT8, KRT19**: Keratins typically expressed in epithelial cells, particularly luminal epithelial cells in the breast.<br>- **CLDN3 (Claudin 3)**: A component of tight junctions in epithelial cells.<br>- **TFAP2C**: A transcription factor associated with luminal epithelial cell differentiation in the breast.<br>- **LY6E**: Often associated with immune response but also expressed in epithelial cells.<br><br>### Step 3: Cross-reference Known Databases<br>Using databases such as the Human Protein Atlas, CellMarker, and literature on breast cancer scRNA-seq datasets, the markers listed are predominantly associated with epithelial cells, particularly luminal epithelial cells in the breast. The presence of keratins (KRT8, KRT18, KRT19) and MUC1 strongly suggests an epithelial origin.<br><br>### Step 4: Determine the Most Probable General Cell Type<br>Based on the expression of epithelial markers (KRT8, KRT18, KRT19, MUC1) and the presence of growth factors and proteins associated with epithelial cell function (AREG, TFF1, TFF3), the most probable general cell type is **epithelial cells**.<br><br>### Step 5: Identify the Top 3 Most Probable Sub Cell Types<br>1. **Luminal Epithelial Cells**: The expression of KRT8, KRT18, KRT19, TFAP2C, and MUC1 strongly indicates luminal epithelial cells, which are a major component of the breast epithelium.<br>2. **Basal Epithelial Cells**: Although less likely due to the lack of specific basal markers like KRT5 or KRT14, some overlap in marker expression can occur.<br>3. **Myoepithelial Cells**: Least likely due to the absence of myoepithelial-specific markers such as ACTA2 or MYH11.<br><br>The most likely subtype based on the markers is **Luminal Epithelial Cells**.<br><br>### Step 6: Provide a Concise Summary of Your Analysis<br>The analysis of the ranked marker list from the breast cancer tissue dataset suggests that the cell cluster is composed of epithelial cells, with a high probability of being luminal epithelial cells. This conclusion is supported by the expression of keratins (KRT8, KRT18, KRT19), MUC1, and other markers associated with luminal epithelial differentiation and function.<br><br>**FINAL ANNOTATION COMPLETED**
                </div>
            
                <div class="agent-section validator">
                    <h2>‚úì Validation Check</h2>
                    <div class="validation-result">‚úÖ VALIDATION PASSED</div>
                    Validation result: VALIDATION PASSED<br><br>The proposed annotation result is consistent with the provided marker list and the identified cell type. Here's the breakdown:<br><br>1. **Marker Consistency**: <br>   - The key functional markers and cell type markers listed in the annotation (e.g., S100A7, TFF1, AREG, KRT18, KRT8, KRT19, MUC1, TFAP2C, CLDN3, LY6E) are all present in the provided marker list.<br>   - The markers are consistent with the identification of epithelial cells, particularly luminal epithelial cells, as they are known to express these markers.<br><br>2. **Mixed Cell Type Consideration**:<br>   - The annotation considers the possibility of basal epithelial cells and myoepithelial cells but concludes that luminal epithelial cells are the most likely subtype based on the marker expression.<br>   - There is no strong evidence of mixed cell types supported by several high-ranking markers, so the annotation does not need to be flagged for further investigation.<br><br>The annotation accurately reflects the data provided and aligns with known literature and databases regarding breast epithelial cell markers.
                </div>
            
                        <div class="agent-section formatting">
                            <h2>üìã Summary</h2>
                            
                        <div class="summary-content">
                            <div class="summary-item">
                                <span class="summary-label">Main Cell Type:</span>
                                <span class="summary-value">Epithelial Cells</span>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Sub Cell Types:</span>
                                <ul class="summary-list">
                                    <li>Luminal Epithelial Cells</li><li>Basal Epithelial Cells</li><li>Myoepithelial Cells</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Possible Mixed Cell Types:</span>
                                <ul class="summary-list">
                                    <li class="empty-list">No mixed cell types identified</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Number of Markers:</span>
                                <span class="summary-value">50</span>
                            </div>
                        </div>
                    
                        </div>
                    
                    <div class="agent-section scoring">
                        <h2>üéØ Quality Assessment</h2>
                        <div class="score-badge">95</div>
                        <div class="scoring-content">
                            The annotation results provided demonstrate a strong understanding of the single-cell data derived from breast cancer tissue. The analysis correctly identifies the main cell type as epithelial cells, with a high probability of being luminal epithelial cells. This conclusion is well-supported by the presence of key markers such as KRT8, KRT18, KRT19, and MUC1, which are characteristic of luminal epithelial cells in the breast.<br><br>1. **Correctness of the Annotations**: The annotations are scientifically accurate. The markers identified are consistent with known literature and databases regarding breast epithelial cell markers. The analysis correctly identifies the main cell type and the most probable subtypes, with luminal epithelial cells being the most likely.<br><br>2. **Balanced Consideration of Multiple Markers**: The annotation process demonstrates a balanced consideration of multiple markers. It does not overly focus on a single marker but rather considers a range of markers, including functional markers (e.g., S100A7, TFF1, AREG) and cell type markers (e.g., KRT18, KRT8, KRT19, MUC1, TFAP2C, CLDN3, LY6E). This comprehensive approach strengthens the validity of the conclusions drawn.<br><br>3. **Ability to Capture the General Picture**: The annotation provides a comprehensive view of the cell types present. It considers the possibility of mixed cell types, such as basal epithelial cells and myoepithelial cells, but appropriately concludes that luminal epithelial cells are the most likely subtype based on the marker expression. The analysis captures the general picture of the cell populations effectively.<br><br>4. **Consideration of Marker Rank**: The annotation does not explicitly discuss the rank of the markers, which could be an area for improvement. However, the markers identified as key are indeed high-ranking and relevant to the cell type identification.<br><br>Overall, the annotation is thorough, scientifically sound, and provides a clear and accurate picture of the cell populations present in the dataset. There are no obvious misclassifications or oversights, and the analysis aligns well with known data on breast epithelial cells.<br>
                        </div>
                    </div>
                
        </div>
    </body>
    </html>
    